Genomics Services
 
 
SLCO1B1 Test (For Statin Induced Myopathy)
SLCO1B1 (solute carrier organic anion transporter family, member 1B1) is a protein-coding gene. The genomewide study has identified common genetic variants in SLCO1B1 that are associated with substantial alterations in the risk of simvastatin-induced myopathy. Simvastatin is a commonly prescribed first generation hypolipidemic drug used for cholesterol reduction and control. Increase in statin dosage is closely associated with increased risk of muscular toxicity. The clinical spectrum of statin induced myopathy also includes asymptomatic increase in the concentration of creatine kinase. Adverse drug reactions of statin may be associated with genetically linked variants of SLCO1B1.

Sample Type

Blood Sample: 5 ml blood in EDTA Vacutainer at 2-8°C
 
Brochure           inquiry
 
 
MYBPC3 Test (For Hypertropic Cardiomyopathy)   |   SLCO1B1 Test (For Statin Induced Myopathy)
Warfarin   |   Clopidogrel
 
 
Click Here to Zoom
 
Click Here to Zoom
 
Click Here to Zoom
 
Click Here to Zoom